Papillary thyroid cancer patients with LND 0.19 have worse disease-specific, overall survival, researchers found.
Using the statewide Utah Population Database, investigators sought to determine the long-term effects of thyroid cancer on survivors who were younger than 40 years at diagnosis.
Risk of Thyroid Cancer Increased With Fruit Juice Consumption, No Effect With Fruit and Vegetable ConsumptionJuly 26, 2017
No correlation was found between fruit and vegetable consumption and the risk of differentiated thyroid cancer, but a positive trend may be associated with fruit juice intake.
Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older PatientsJune 27, 2017
Results from a sub-analysis of the impact of age on the safety and efficacy of lenvatinib in patients with RR-DTC in the SELECT trial showed that lenvatinib significantly increased PFS.
Immunotherapy regimens FDA-approved for the treatment of melanoma may also be an option for a rare and aggressive form of papillary thyroid cancer.
Although screening is often recommended as the first line of prevention for most cancers, recent recommendation from the USPSTF advises against thyroid cancer screening in nonsymptomatic adults.
Thyroid is more likely to be managed with surgical intervention when patients have access to expanded health insurance.
A report on incidence of thyroid cancer shows incidence of the disease is increasing among certain populations: younger persons, Hispanic, and African American.
Increase mainly due to papillary thyroid cancer, which increased in incidence for all SEER stages at diagnosis
Deciding not to intervene for small, incidentally identified thyroid cancer may cause patients to experience anxiety and feelings of isolation.
[OncoTargets and Therapy] This research presents an overview of patient and disease management in pediatric pediatric papillary thyroid (PTC) patients.
Widespread routine thyroid cancer screening can lead to overdiagnosis and overtreatment, the USPSTF contends.
Quality of Life and Cosmetic Result of Single-port Access Endoscopic Thyroidectomy via Axillary Approach in Patients with papillary thyroid carcinomaAugust 18, 2016
[OncoTargets and Therapy] This research reviews the effects of single-port access transaxillary totally endoscopic thyroidectomy on outcomes following surgery, including quality of life and cosmetic result, in patients with papillary thyroid carcinoma (PTC).
Patients with medullary thyroid cancer who harbor RET M918T or RAS mutations may derive greater clinical benefit from cabozantinib compared with patients who do not have those genetic mutations.
There were no effective therapeutic options for advanced thyroid cancer until 5 years ago.
Scientists developed an innovative nanoplatform to more effectively deliver RNA interference to anaplastic thyroid cancer (ATC) sites. ATC is the most aggressive form of thyroid cancer; mortality is almost 100% and median survival is 3 to 5 months.
In women of reproductive age who have thyroid cancer, their remaining egg supply is affected by radioactive iodine treatment, potentially reducing their fertility.
Review found increased odds for developing thyroid or breast cancer as secondary malignancy after the other cancer type was diagnosed.
Treatment with sorafenib in patients with progressive metastatic medullary thyroid cancer (MTC) is well tolerated and resulted in disease control.
Elderly patients can safely undergo thyroid surgery with careful preoperative screening. The procedure was found to be no more dangerous in patients older than 65 years than in those ages 21 to 35 years.
Survivors of thyroid cancer report their quality of life after diagnosis and treatment as poor compared with patients whose diagnoses are more lethal cancers.
To test thyroid malignancy, many biomarkers are tested separately to confirm cancer. However, new research shows that the tests used to measure 2 major biomarkers in the diagnosis of thyroid cancer may be inaccurate.
A recent discovery may lead to the development of a cell-based regenerative therapy for restoring thyroid function in cancer patients after thyroidectomy and in children born with congenital hypothyroidism.
New, evidence-based recommendations from the American Thyroid Association will help guide the management of thyroid nodules. The new guidelines also focus on diagnosis and management of DTC, an increasingly prevalent form of cancer.
Children living near the Fukushima nuclear meltdowns in Japan have a much higher rate of thyroid cancer diagnoses than that of children elsewhere.
Positive link made between obesity and papillary, follicular, and anaplastic thyroid cancer; inverse link for medullary thyroid cancer.
Low-risk cancers that are asymptomatic and presumably will not cause problems in the future are responsible for the rapid increase in the number of new thyroid cancer diagnoses over the past decade, according to a study.
What would be the ideal TSH level for patients after total thyroidectomy for cancer of the papillary thyroid?
When multiple HDAC inhibitors were tested in combination with the chemotherapy drug paclitaxel, class II HDAC inhibitors signaled through a newly discovered pathway to promote synergy with chemotherapy treatment.
The newly developed NIR contrast agents can aid surgeons is distinguishing the thyroid and parathyroid glands from each other and from the surrounding tissue.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|